A critical role for αKG-dependent epigenetic modulation in CSC has been demonstrated in glioma-initiating cells, in which upregulation of wild-type IDH1 activates oxidative decarboxylation of citrate to increase αKG levels. Here, IDH1 is linked to central nervous system cancer.